Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Michael Birrer

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Birrer, Michael

Item TypeName
Concept Antibiotics, Antineoplastic
Concept Acetyl-CoA Carboxylase
Concept Antigens, Viral
Concept Acetylcysteine
Concept Sodium-Potassium-Exchanging ATPase
Concept Aminopterin
Concept Alkaloids
Concept Carbazoles
Concept Antimetabolites, Antineoplastic
Concept Antibodies, Viral
Concept Antigens, Neoplasm
Concept Amino Acid Chloromethyl Ketones
Concept Antineoplastic Agents
Concept Carnitine O-Palmitoyltransferase
Concept Benzamides
Concept Collagen
Concept Bombesin
Concept Ceramides
Concept Cyclodextrins
Concept Cisplatin
Concept Creatinine
Concept Dexamethasone
Concept Flavonoids
Concept Actins
Concept Benzimidazoles
Concept Contractile Proteins
Concept Drug Evaluation
Concept Contrast Media
Concept Endoribonucleases
Concept Diamines
Concept Drug Evaluation, Preclinical
Concept Endonucleases
Concept Drug Implants
Concept Antineoplastic Agents, Phytogenic
Concept Aminopyridines
Concept Acetamides
Concept Cyclic AMP
Concept Epitopes
Concept Asparaginase
Concept Antibodies, Anti-Idiotypic
Concept Aldehyde Reductase
Concept Antiemetics
Concept Aspartate-Ammonia Ligase
Concept Antibodies, Monoclonal
Concept Heterocyclic Compounds, 3-Ring
Concept Aldehyde Dehydrogenase
Concept Estradiol
Concept Exons
Concept Benzenesulfonates
Concept Fatty Acids
Concept Fibroblast Growth Factors
Concept Calcium-Binding Proteins
Concept Camptothecin
Concept Carbolines
Concept Cytarabine
Concept Azacitidine
Concept Benzodiazepines
Concept Microtubule-Associated Proteins
Concept Hydrogen Peroxide
Concept Dose-Response Relationship, Drug
Concept Carrier Proteins
Concept Arginine Vasopressin
Concept Bufanolides
Concept Binding Sites
Concept Cyclophosphamide
Concept Fungal Proteins
Concept Genetic Vectors
Concept Histone Deacetylases
Concept Cytoskeletal Proteins
Concept Chromones
Concept Base Sequence
Concept Hormones, Ectopic
Concept Carcinogens
Concept Hormones
Concept Deoxyribonuclease I
Concept Doxorubicin
Concept Eosine Yellowish-(YS)
Concept Epidermal Growth Factor
Concept Microtubule Proteins
Concept Enzyme Inhibitors
Concept Eye Proteins
Concept Transcription Factors
Concept Dipeptides
Concept DNA-Binding Proteins
Concept Fluorescent Dyes
Concept Ophthalmic Solutions
Concept Estrogens
Concept Gastrins
Concept Follicle Stimulating Hormone
Concept Formaldehyde
Concept Phenanthridines
Concept Phorbol Esters
Concept Protein Kinase C
Concept Drug Synergism
Concept Polylysine
Concept Globins
Concept Interferon-gamma
Concept Hepatocyte Growth Factor
Concept Prostaglandin-Endoperoxide Synthases
Concept Protein Kinases
Concept Polyethylene Glycols
Concept Promoter Regions, Genetic
Concept Pyrimidines
Concept Receptors, Glucocorticoid
Concept Ribonucleases
Concept Serine
Concept Morpholines
Concept Lovastatin
Concept Quinoxalines
Concept Cytotoxins
Concept Membrane Proteins
Concept Stereoisomerism
Concept Tablets
Concept Membrane Glycoproteins
Concept Oncogene Proteins, Viral
Concept Plasmids
Concept Luminescent Proteins
Concept Caspases
Concept Glycoproteins
Concept Growth Inhibitors
Concept Platinum
Concept Drug Design
Concept Phenylurea Compounds
Concept Protein-Tyrosine Kinases
Concept Mitogens
Concept Retinoids
Concept RNA, Viral
Concept HMGA1a Protein
Concept Receptors, Vasoactive Intestinal Peptide
Concept Neurotransmitter Agents
Concept Isoenzymes
Concept Transforming Growth Factor beta
Concept Urea
Concept Nitrogen Oxides
Concept Organometallic Compounds
Concept Interleukin-6
Concept Oxidants
Concept Transferrin
Concept Receptors, Peptide
Concept ATP-Binding Cassette Transporters
Concept Apolipoprotein A-I
Concept Proteins
Concept Calcium
Concept Capsules
Concept RNA, Small Interfering
Concept CDC2-CDC28 Kinases
Concept Receptors, Retinoic Acid
Concept Drug Monitoring
Concept Acid Anhydride Hydrolases
Concept Proto-Oncogene Proteins
Concept Phosphoserine
Concept Gastrin-Releasing Peptide
Concept Cytochromes c
Concept RNA
Concept Adenosylmethionine Decarboxylase
Concept Somatomedins
Concept Peptide Fragments
Concept Repressor Proteins
Concept Gonadal Steroid Hormones
Concept Oncogene Proteins
Concept GTP-Binding Proteins
Concept Cyclin E
Concept Trans-Activators
Concept Cell Adhesion Molecules
Concept Alternative Splicing
Concept CA-125 Antigen
Concept Proto-Oncogene Proteins c-raf
Concept Cyclin-Dependent Kinase Inhibitor p16
Concept Cyclooxygenase 2
Concept Benzophenanthridines
Concept Matrix Metalloproteinases, Membrane-Associated
Concept BRCA1 Protein
Concept Dual Specificity Phosphatase 1
Concept Receptor, TIE-2
Concept Recombinant Proteins
Concept cdc42 GTP-Binding Protein
Concept Calcineurin
Concept Mitogen-Activated Protein Kinase 9
Concept Tetradecanoylphorbol Acetate
Concept Proto-Oncogene Proteins c-fos
Concept Cyclic AMP Response Element-Binding Protein
Concept Receptors, Fibroblast Growth Factor
Concept TNF-Related Apoptosis-Inducing Ligand
Concept Veratrum Alkaloids
Concept ADP-ribosyl Cyclase
Concept Ionomycin
Concept Matrix Metalloproteinase 2
Concept Neuropilin-1
Concept Fibroblast Growth Factor 1
Concept Proto-Oncogene Proteins p21(ras)
Concept Homeodomain Proteins
Concept Cyclin A
Concept Proto-Oncogene Proteins B-raf
Concept Early Growth Response Protein 1
Concept Matrix Metalloproteinase 7
Concept beta Karyopherins
Concept Activin Receptors, Type I
Concept Chemokine CXCL12
Concept Monomeric GTP-Binding Proteins
Concept Immunoconjugates
Concept Thiourea
Concept Phosphatidylserines
Concept Karyopherins
Concept Angiopoietin-2
Concept Isotretinoin
Concept Response Elements
Concept 3' Untranslated Regions
Concept Gadolinium
Concept Class I Phosphatidylinositol 3-Kinases
Concept MAP Kinase Kinase 1
Concept MAP Kinase Kinase 2
Concept Fluocinolone Acetonide
Concept DNA
Concept Doxycycline
Concept Hematoxylin
Concept Lipopolysaccharides
Concept Luciferases
Concept Piperazines
Concept Receptors, Pituitary Hormone
Concept Gene Library
Concept Carboplatin
Concept NF-kappa B
Concept Genes, jun
Concept HSP70 Heat-Shock Proteins
Concept Angiogenesis Inhibitors
Concept Receptor Protein-Tyrosine Kinases
Concept Chitosan
Concept MAP Kinase Kinase 4
Concept Receptor, Notch2
Concept Neuropeptides
Concept Phthalazines
Concept Pyrroles
Concept RNA, Messenger
Concept Sodium Chloride
Concept Proto-Oncogene Proteins c-jun
Concept Histone-Lysine N-Methyltransferase
Concept Vimentin
Concept Paclitaxel
Concept DEAD-box RNA Helicases
Concept Mitogen-Activated Protein Kinase 3
Concept Tumor Suppressor Protein p53
Concept Proto-Oncogene Proteins c-myc
Concept DNA, Neoplasm
Concept Drug Hypersensitivity
Concept Erythropoietin
Concept Transcription Factor AP-1
Concept Receptors, Interleukin-8B
Concept Receptors, Vascular Endothelial Growth Factor
Concept Taxoids
Concept Receptors, Scavenger
Concept Glycogen Synthase Kinases
Concept Adaptor Proteins, Signal Transducing
Concept NFATC Transcription Factors
Concept PTEN Phosphohydrolase
Concept Transcription Factor RelB
Concept DNA Primers
Concept Onium Compounds
Concept Cyclin-Dependent Kinase Inhibitor p21
Concept bcl-X Protein
Concept Wnt Proteins
Concept Glucose
Concept Growth Substances
Concept Small Molecule Libraries
Concept Apoptosis Regulatory Proteins
Concept Pituitary Adenylate Cyclase-Activating Polypeptide
Concept Versicans
Concept Vitamin E
Concept Chemokine CXCL2
Concept Protein Phosphatase 1
Concept NM23 Nucleoside Diphosphate Kinases
Concept Receptors, Transforming Growth Factor beta
Concept Troponin C
Concept Oncogene Protein p21(ras)
Concept Antigens, CD
Concept Immediate-Early Proteins
Concept Receptors, Cytoplasmic and Nuclear
Concept Inflammation Mediators
Concept Drug Delivery Systems
Concept Ondansetron
Concept Drug Compounding
Concept Drug Therapy, Combination
Concept Cyclin-Dependent Kinases
Concept Bleomycin
Concept Deoxycytidine
Concept DNA, Single-Stranded
Concept Matrix Metalloproteinase 14
Concept Interleukin-1alpha
Concept Amyloid Precursor Protein Secretases
Concept Drug Discovery
Concept Antigens, CD34
Concept HLA-D Antigens
Concept Indazoles
Concept Insulin
Concept Quinazolines
Concept Receptors, Progesterone
Concept Thiazoles
Concept Thymosin
Concept Drug Industry
Concept Organoplatinum Compounds
Concept Atrial Natriuretic Factor
Concept Vinblastine
Concept Viral Proteins
Concept Cyclin-Dependent Kinase 2
Concept Smad Proteins
Concept JNK Mitogen-Activated Protein Kinases
Concept Extracellular Signal-Regulated MAP Kinases
Concept Tubulin Modulators
Concept Glucocorticoids
Concept Estrogen Antagonists
Concept Receptor, Fibroblast Growth Factor, Type 4
Concept I-kappa B Kinase
Concept Matrix Metalloproteinase 3
Concept Sirolimus
Concept Green Fluorescent Proteins
Concept Proto-Oncogene Proteins c-mdm2
Concept Hypoxia-Inducible Factor 1, alpha Subunit
Concept Ligands
Concept Iodine Radioisotopes
Concept Indoles
Concept Hydroquinones
Concept Interleukin-2
Concept Proto-Oncogene Proteins c-myb
Concept ras-GRF1
Concept Matrix Metalloproteinase 9
Concept BRCA2 Protein
Concept Connective Tissue Growth Factor
Concept Heterocyclic Compounds
Concept Maytansine
Concept Guanosine Triphosphate
Concept Antibodies, Monoclonal, Humanized
Concept Luteinizing Hormone
Concept 5-Lipoxygenase-Activating Proteins
Concept Saccharomyces cerevisiae Proteins
Concept Quinones
Concept Metalloendopeptidases
Concept Gases
Concept Oligonucleotides
Concept LIM-Homeodomain Proteins
Concept Heat-Shock Proteins
Concept Ice
Concept Nitrogen Isotopes
Concept Naphthalenes
Concept Oligopeptides
Concept Oxazines
Concept Phosphoric Monoester Hydrolases
Concept Phosphoproteins
Concept Prealbumin
Concept Clusterin
Concept Kruppel-Like Transcription Factors
Concept Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
Concept Receptors, Antigen, T-Cell
Concept Ornithine Decarboxylase
Concept Regulatory Sequences, Nucleic Acid
Concept Piperidines
Concept Pyrazoles
Concept Protease Inhibitors
Concept Pyridines
Concept Ki-67 Antigen
Concept RNA-Binding Proteins
Concept Receptors, Androgen
Concept RNA, Neoplasm
Concept Phosphatidylinositol 3-Kinases
Concept Extracellular Matrix Proteins
Concept ras Proteins
Concept Pyrimidinones
Concept Tumor Suppressor Proteins
Concept Tubulin
Concept Tumor Necrosis Factor-alpha
Concept Poly(ADP-ribose) Polymerases
Concept DNA Probes, HPV
Concept Urokinase-Type Plasminogen Activator
Concept Cysteine Proteinase Inhibitors
Concept Tamoxifen
Concept Receptors, Estrogen
Concept Repetitive Sequences, Nucleic Acid
Concept Tetracycline
Concept DNA, Antisense
Concept MAP Kinase Kinase Kinases
Concept Serum Response Element
Concept Intracellular Signaling Peptides and Proteins
Concept Epothilones
Concept Retroviridae Proteins, Oncogenic
Concept Single-Strand Specific DNA and RNA Endonucleases
Concept Phosphoprotein Phosphatases
Concept Sodium Salicylate
Concept Anticarcinogenic Agents
Concept Oncogene Proteins v-mos
Concept Cell Cycle Proteins
Concept Sulfonamides
Concept Protein Tyrosine Phosphatases
Concept Reactive Oxygen Species
Concept Intercellular Signaling Peptides and Proteins
Concept Vascular Endothelial Growth Factor Receptor-2
Concept Megestrol Acetate
Concept Apoptosis
Concept Platinum Compounds
Concept DNA, Complementary
Concept Tretinoin
Concept Chloramphenicol O-Acetyltransferase
Concept Cyclin D1
Concept Triazines
Concept Vasoactive Intestinal Peptide
Concept Proto-Oncogene Proteins c-kit
Concept Proteome
Concept Mitogen-Activated Protein Kinase Kinases
Concept Drug Resistance, Neoplasm
Concept Retinal Dehydrogenase
Concept STAT3 Transcription Factor
Concept CCAAT-Enhancer-Binding Proteins
Concept Protein Kinase Inhibitors
Concept Stathmin
Concept Cyclins
Concept Receptors, CXCR4
Concept Long Interspersed Nucleotide Elements
Concept Anti-Mullerian Hormone
Concept Transforming Growth Factor beta1
Concept Papillomavirus E7 Proteins
Concept Polycomb Repressive Complex 2
Concept Cyclin-Dependent Kinase 4
Concept Aquaporin 2
Concept Receptor, Fibroblast Growth Factor, Type 2
Concept Retinoblastoma Protein
Concept Free Radical Scavengers
Concept GABA Plasma Membrane Transport Proteins
Concept Erythroid-Specific DNA-Binding Factors
Concept Drug Administration Schedule
Concept Drug Screening Assays, Antitumor
Concept Receptor, erbB-2
Concept Proto-Oncogene Proteins c-met
Concept Mitogen-Activated Protein Kinase 1
Concept Osteonectin
Concept Folate Receptor 1
Concept Calcium-Calmodulin-Dependent Protein Kinases
Concept Mucin-1
Concept Mitogen-Activated Protein Kinases
Concept Topotecan
Concept Matrix Metalloproteinases
Concept GATA1 Transcription Factor
Concept Ribonuclease III
Concept Basic-Leucine Zipper Transcription Factors
Concept Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
Concept Caspase 3
Concept Elafin
Concept Neoplasm Proteins
Concept Caspase Inhibitors
Concept Nanotubes, Carbon
Concept Vascular Endothelial Growth Factor A
Concept Proto-Oncogene Proteins c-bcl-2
Concept Tissue Inhibitor of Metalloproteinase-1
Concept Cyclin A2
Concept Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
Concept Cyclin-Dependent Kinase Inhibitor p27
Concept Proteasome Endopeptidase Complex
Concept Tocopherols
Concept Focal Adhesion Protein-Tyrosine Kinases
Concept Forkhead Transcription Factors
Concept LIM Domain Proteins
Concept Hedgehog Proteins
Concept Basic Helix-Loop-Helix Transcription Factors
Concept Retinoid X Receptors
Concept Transcription Factor RelA
Concept TOR Serine-Threonine Kinases
Concept CTLA-4 Antigen
Concept Chemokine CXCL1
Concept Peptides
Concept Pyridones
Concept Oligonucleotides, Antisense
Concept Protein Isoforms
Concept MicroRNAs
Concept Proto-Oncogene Proteins c-akt
Concept G-Box Binding Factors
Concept GPI-Linked Proteins
Concept Niacinamide
Concept Nuclear Proteins
Concept Recombinant Fusion Proteins
Concept Sphingosine
Concept Integrins
Concept Cytokines
Concept Fenretinide
Concept Receptors, Aryl Hydrocarbon
Concept Receptor, Platelet-Derived Growth Factor beta
Concept Oncogene Proteins v-raf
Concept Symporters
Concept Telomere-Binding Proteins
Concept p38 Mitogen-Activated Protein Kinases
Concept Transcription Factor CHOP
Concept NF-kappa B p50 Subunit
Concept p21-Activated Kinases
Academic Article A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24.
Academic Article Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Academic Article Targeting the Nuclear Import Receptor Kpn?1 as an Anticancer Therapeutic.
Academic Article Characterization of folate receptor alpha (FRa) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRa-targeting antibody-drug conjugate mirvetuximab soravtansine.
Academic Article Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.
Academic Article A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Academic Article Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
Academic Article Better therapeutic trials in ovarian cancer.
Academic Article BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Academic Article Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer.
Academic Article Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
Academic Article Novel therapeutic targets.
Academic Article An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.
Academic Article Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.
Academic Article Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.
Academic Article Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer.
Academic Article Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents.
Academic Article Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine.
Academic Article Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
Academic Article Antibody-Drug Conjugate-Based Therapeutics: State of the Science.
Academic Article Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer.
Academic Article Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.
Academic Article IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.
Academic Article Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer.
Academic Article A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer.
Academic Article Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
Academic Article Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
Academic Article Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.
Academic Article Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.
Academic Article FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer.
Academic Article Ovarian cancer: targeting the untargetable.
Academic Article Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
Academic Article Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials.
Academic Article Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes.
Academic Article Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.
Academic Article NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide.
Academic Article CLINICAL DECISIONS. Chemotherapy-Induced Nausea and Vomiting.
Academic Article Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer.
Academic Article Olaparib and a-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
Academic Article ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells.
Academic Article Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor a-targeting antibody-drug conjugate, in patients with solid tumors.
Academic Article Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models.
Academic Article A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.
Academic Article Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Academic Article Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Grant Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
Academic Article Growth factors and other targets for rational application as intervention agents.
Academic Article PACAP stimulates c-fos mRNAs in small cell lung cancer cells.
Academic Article Cooperation between retinoic acid and phorbol esters enhances human teratocarcinoma differentiation.
Academic Article Use of transcription factors as agents and targets for drug development.
Academic Article The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin.
Academic Article Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer.
Academic Article Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer.
Academic Article Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study.
Academic Article Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.
Academic Article Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of M?llerian origin.
Academic Article Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929).
Academic Article Inhibition of Kpn?1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
Academic Article Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary?analysis of FORWARD I.
Academic Article Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Academic Article A highly annotated database of genes associated with platinum resistance in cancer.
Academic Article Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer.

Search Criteria
  • drug